Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-29

Clinical Trial Update: Sunphenon in Progressive Forms of Multiple Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Sunphenon in progressive forms of multiple sclerosis, encompassing Phase 2 and Phase 3 completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sunphenon

Snippet

Sponsor: Friedemann Paul | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED